Brief: Inhibrx to host webcast presentation to provide clinical update on INBRX-106 HexAgon study in first line HNSCC
08/05/2026 21:03
May 8 (Reuters) - Inhibrx Biosciences Inc INBX.O: INHIBRX TO HOST WEBCAST PRESENTATION TO PROVIDE CLINICAL UPDATE ON INBRX-106 HEXAGON STUDY IN FIRST LINE HNSCC Source text: ID:nPn53DDr5a Further company coverage: INBX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Inhibrx
See all newsInhibrx Q1 net loss narrows as R&D costs fall
Brief: Inhibrx Reports Interim Phase 2 Data for INBRX-106 in First-Line HNSCC; Initial Results Demonstrate Potential Costimulatory Benefit Over PD-1 Monotherapy
Brief: Inhibrx to host webcast presentation to provide clinical update on INBRX-106 HexAgon study in first line HNSCC
Merck, rivals eye Inhibrx experimental cancer drug tied to Keytruda, sources say
U.S. STOCKS ON THE MOVE-Tesla, AT&T, Yesway